Immunology
Global

Immunology Experts

Dominique Le Beller

CEO of DEINOBIOTICS
immunology
deinove
Liechtenstein

Biography

Education: Biological Engineer with a Doctorate in Microbiology, Bioconversions and Enzymology (Université de Technologie de Compiègne). Career: Dominique LE BELLER spent his all career in the Pharma industry (HOESCHST-MARION-ROUSSEL, AVENTIS) researching on ati-infective agents and notably contributed to the development of 3 antibiotics: Ketek®, NXL 201 and NXL 104. With the Institut Pasteur, he also played an active role in the creation and implementation of the "Infectology" subject at the Pole MEDICEN, and launched the first "chemical library" project. In 2004,

Research Interest

Career: Dominique LE BELLER spent his all career in the Pharma industry (HOESCHST-MARION-ROUSSEL, AVENTIS) researching on ati-infective agents and notably contributed to the development of 3 antibiotics: Ketek®, NXL 201 and NXL 104. With the Institut Pasteur, he also played an active role in the creation and implementation of the "Infectology" subject at the Pole MEDICEN, and launched the first "chemical library" project. In 2004, Dominique LE BELLER co-founded Novexel and directed projects, operations and human resources at this start-up specialized in the development of anti-infective agents until it was bought by Astra Zeneca for nearly $500 million in 2010.

Global Experts from Liechtenstein

Global Experts in Subject

Share This Profile
Recommended Conferences
View more
Relevant Topics